For physicians
An mCRPC patient with ATM loss-of-function identified on prior testing. One blood draw. The 104-gene panel returns a ranked report of PARP inhibitor and HRR-targeted trials currently recruiting for that variant profile. The report goes to you. No data leaves your network.
Independent urologists and oncologists order the 104-gene ctDNA panel through their existing laboratory relationship. Every result generates a structured match report: variant-to-profile alignment, eligibility criteria matched against the submitted panel, and recruiting status at time of query. Credentialing requires NPI verification only. No hospital affiliation. No institutional contract.
48 hrs
Credentialing turnaround
Low
Screen failure rate — credentialed network
27
Registered Atumnus studies — FDAAA 801
NPI only
Credentialing requirement — no institutional contract
Credentialing and ordering
NPI-direct. Sub-investigator agreement. Gene-to-therapy matrix. Match report delivery.
01
NPI-verified credentialing
Apply with your NPI number and specialty attestation. No hospital affiliation required. No institutional contract. Approval in 48 hours.
02
Structured ordering framework
Field-by-field clinical ordering triggers define when a patient qualifies for the 104-gene panel. Gene-to-therapy matrix maps results to specific recruiting trials.
03
Sub-investigator agreement
Approved physicians sign a sub-investigator agreement designating them as site investigator on Atumnus-registered studies. Agreement terms are established per IRB-approved protocol. No health system intermediary required.
04
Match report delivery
Every panel result generates a structured match report. Field-by-field eligibility breakdown for each recruiting trial. Shareable with trial coordinators directly.
FAQ
Physician credentialing questions.
Do I need hospital affiliation to apply?
No. VerifiedEnroll credentials independent physicians directly. No institutional contract, no health system affiliation, and no IRB membership required to begin ordering.
What specialties are eligible?
Urology is the primary specialty for the current 104-gene panel. Medical oncology and hematology/oncology are also eligible. Additional specialties will be added as indication coverage expands.
How does the sub-investigator agreement work?
Approved physicians sign a sub-investigator agreement designating them as site investigator on Atumnus-registered studies. Compensation is structured per IRB-approved protocol at fair market value. Terms are established in the signed agreement.
What does the ordering framework include?
The framework provides ordering triggers, a gene-to-therapy matrix mapping panel results to trial eligibility, and a structured match report template for patient communication.
Apply
Physician credentialing application
Credentialing completed within 48 hours of a complete application. No hospital affiliation required.